For: | Li PC, Yun DB, Huang YX, Huang QY. Prognostic significance of oligodendrocyte transcription factor 2 expression in glioma patients: A systematic review and meta-analysis. World J Clin Cases 2024; 12(25): 5739-5748 [PMID: 39247740 DOI: 10.12998/wjcc.v12.i25.5739] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v12/i25/5739.htm |
Number | Citing Articles |
1 |
Zhouyang Xu, Yingying Xi, Yangyang Guo, Chenxi Wang, Yuchen Shi, Doudou Sun, Yuan Zhang, Faqing Ye, Xuemei Xu, Xuebao Wang. Discovery of novel pyrimidine-4,6-diamine-based OLIG2 inhibitors as potent anti-glioblastoma agents. European Journal of Medicinal Chemistry 2025; 298: 118009 doi: 10.1016/j.ejmech.2025.118009
|
2 |
Andrea Pop-Crisan, Radu Pirlog, Lavinia-Lorena Pruteanu, Constantin Busuioc, Ovidiu-Laurean Pop, Deo Prakash Pandey, Cornelia Braicu, Ioana Berindan-Neagoe. ATRX, OLIG2, MGMT, and IDH2 in Glioblastoma: Essential Molecular Mechanisms and Therapeutic Significance. Medicina 2025; 61(4): 697 doi: 10.3390/medicina61040697
|